| n (%) | |||
| Gender | |||
| Female | 42 (51.9) | ||
| Male | 39 (48.1) | ||
| Age | ranged from | 1 to 78 yrs (mean age 28.4) | |
| Clinical type | |||
| Segmental | 36 (44.4) | ||
| Nonsegmental | 30 (37.1) | ||
| Unclassified | 15 (18.5) | ||
| Lesion sites for observation | |||
| Face/neck | 47 (58) | ||
| Trunk | 22 (27.2) | ||
| Limb | 8 (9.9) | ||
| Acral | 4 (4.9) | ||
| Treatment option | |||
| Topical | Steroid alone | 3 (4.5) | |
| TCI (topical calcineurin inhibitor) alone | 1 (1.5) | ||
| Vit. D3 alone | 5 (7.6) | ||
| Combined | 23 (34.8) | ||
| with phototherapy* | 22 (33.3) | ||
| Systemic steroid | 12 (18.2) | ||
| Initial feature | |||
| Inside | Clear white | 13 (16.9) | |
| Faint | 22 (28.6) | ||
| Multi-dot | 26 (33.8) | ||
| Perifollicular | 16 (20.8) | ||
| Border | Sharp | 23 (29.9) | |
| Blunt | 40 (51.9) | ||
| Confetti | 11 (14.3) | ||
| Trichrome | 3 (3.9) | ||
| Frequency of each repigmentation pattern | 53 out of 72 | ||
| Marginal | 10 (18.9) | ||
| Diffuse | 7 (13.2) | ||
| Perifollicular | 5 (9.4) | ||
| Mixed | 31 (58.5) | ||
| Repigmentation | |||
| Present | 55 (67.9) | ||
| Absent | 17 (21) | ||
| Exacerbated** | 4 (4.9) | ||
| Missing | 5 | ||